Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

Lancet
Christian T RuffElliott M Antman

Abstract

New oral anticoagulants for stroke prevention in atrial fibrillation were developed to be given in fixed doses without the need for the routine monitoring that has hindered usage and acceptance of vitamin K antagonists. A concern has emerged, however, that measurement of drug concentration or anticoagulant activity might be needed to prevent excess drug concentrations, which significantly increase bleeding risk. In the ENGAGE AF-TIMI 48 trial, higher-dose and lower-dose edoxaban were compared with warfarin in patients with atrial fibrillation. Each regimen incorporated a 50% dose reduction in patients with clinical features known to increase edoxaban drug exposure. We aim to assess whether adjustment of edoxaban dose in this trial prevented excess drug concentration and the risk of bleeding events. We analysed data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. We correlated edoxaban dose, plasma concentration, and anti-Factor Xa (FXa) activity and compared efficacy and safety outcomes with warfarin stratified by dose reduction status. Patients with atrial fibrillation and at moderate to high risk of stroke were randomly assigned in a 1:1:1 ratio to receive warfarin, dose adjusted to an international normalised rati...Continue Reading

References

Sep 12, 2003·The New England Journal of Medicine·Elaine M HylekDaniel E Singer
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Mar 11, 2006·Stroke; a Journal of Cerebral Circulation·Elena Birman-DeychBrian F Gage
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Sep 30, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammUNKNOWN ESC Committee for Practice Guidelines
Apr 15, 2011·The New England Journal of Medicine·B Nhi BeasleyRobert Temple
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Mar 9, 2012·Thrombosis and Haemostasis·Daniel E SalazarShashank Rohatagi
Jun 29, 2013·The Canadian Journal of Cardiology·Aaron LiewRobert G Hart
Nov 21, 2013·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN ENGAGE AF-TIMI 48 Investigators

❮ Previous
Next ❯

Citations

Oct 17, 2015·Expert Review of Cardiovascular Therapy·Noel C ChanJohn W Eikelboom
Dec 15, 2015·Expert Review of Cardiovascular Therapy·Gualtiero Palareti, Daniela Poli
Nov 13, 2015·Expert Opinion on Pharmacotherapy·Mikhail S Dzeshka, Gregory Y H Lip
May 23, 2015·Expert Opinion on Drug Safety·Jonathan DouxfilsJean-Michel Dogné
Oct 30, 2015·Thrombosis and Haemostasis·J DouxfilsF Mullier
Nov 1, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Steen HustedWillemijn J Comuth
Apr 16, 2016·International Journal of Cardiology·Ramyashree TummalaRaktim Kumar Ghosh
Sep 16, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Paul L McCormack
Jun 13, 2015·European Heart Journal·David Conen
May 15, 2015·Clinical Genetics·G E B Wright
Mar 15, 2015·Lancet·Manesh R Patel, Jeffrey B Washam
Apr 30, 2016·The American Journal of Medicine·Christian T RuffJeffrey I Weitz
Jun 15, 2016·American Heart Journal·James A ReiffelUNKNOWN Cardiac Safety Research Consortium presenters and participants
Jun 15, 2016·Journal of Thrombosis and Haemostasis : JTH·K MartinS Moll
Jun 17, 2016·Expert Opinion on Drug Safety·Paolo Preziosi
Oct 25, 2016·The American Journal of Medicine·Megan E BarraSamuel Z Goldhaber
Sep 24, 2016·Critical Care : the Official Journal of the Critical Care Forum·Karen S BrownJerrold H Levy
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Nov 4, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Paulus KirchhofKatja Zeppenfeld
Sep 10, 2016·Journal of the American College of Cardiology·Jan SteffelChristian T Ruff
Sep 3, 2016·The American Journal of Medicine·John Eikelboom, Geno Merli
Sep 3, 2016·The International Journal of Neuroscience·Jaime Masjuan, Alicia DeFelipe
Sep 25, 2016·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Paulus KirchhofKatja Zeppenfeld
Sep 18, 2016·Hematology/oncology Clinics of North America·Barbara A Konkle
Oct 5, 2016·The American Journal of Emergency Medicine·John Eikelboom, Geno Merli
Sep 2, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hein HeidbuchelPaulus Kirchhof
Dec 6, 2016·Expert Opinion on Pharmacotherapy·Bobby GouinMarc Blondon
Nov 20, 2016·Clinical Transplantation·David M SalernoJaclyn McKeen
Feb 5, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jacob BeyerTyree H Kiser
Jan 4, 2017·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Chan Soon ParkSeil Oh
Jun 28, 2016·Therapeutic Advances in Cardiovascular Disease·Benjamin E PetersonChristopher B Granger
Dec 19, 2015·Therapeutic Advances in Cardiovascular Disease·Alon Eisen, Christian T Ruff
Mar 17, 2017·Journal of Thrombosis and Haemostasis : JTH·J N Berkowitz, S Moll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.